Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.46 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.46 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11842627 | 0.98 | ALDH1A1 (0.47) | ALDH1A1POLBTDP1L3MBTL1LMNA | |
| SCHEMBL12550518 | 0.84 | POLB (0.50) | ALDH1A1POLBTDP1L3MBTL1LMNA | |
| SCHEMBL11176346 | 0.84 | ALDH1A1 (0.43) | ALDH1A1POLBTDP1L3MBTL1LMNA | |
| SCHEMBL28875183 | 0.83 | ALDH1A1 (0.46) | ALDH1A1POLBTDP1L3MBTL1LMNA | |
| SCHEMBL198522 | 0.82 | FSCN1 (0.55) | ALDH1A1POLBTDP1LMNACHRNB2 | |
| SCHEMBL2095575 | 0.82 | ALDH1A1 (0.48) | ALDH1A1POLBTDP1L3MBTL1LMNA | |
| SCHEMBL8986913 | 0.82 | ALDH1A1 (0.48) | ALDH1A1POLBTDP1L3MBTL1LMNA | |
| SCHEMBL11788282 | 0.81 | HDAC1 (0.44) | ALDH1A1POLBMAPTSMN1; SMN2RAB9A | |
| SCHEMBL10942532 | 0.80 | ALDH1A1 (0.47) | ALDH1A1POLBTDP1L3MBTL1LMNA | |
| SCHEMBL18311982 | 0.80 | ALDH1A1 (0.47) | ALDH1A1POLBTDP1L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2406216-B1 | HALOGENALKYLMETHYLENOXY-PHENYL-SUBSTITUTED KETOENOLS | BAYER IP GMBH (DE) | 2017-04-19 | — | — | EP | claimed |
| EP-4680598-A1 | 4-DIFLUOROMETHYL BENZAMIDES WITH HERBICIDAL ACTION | Bayer Aktiengesellschaft (DE) | 2026-01-21 | — | — | EP | disclosed |
| WO-2025224076-A1 | SUBSTITUTED ARYLPYRAZINES AND SALTS THEREOF, AND USE THEREOF AS HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2025-10-30 | — | — | WO | disclosed |
| EP-4602036-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | Bayer Aktiengesellschaft (DE) | 2025-08-20 | — | — | EP | disclosed |
| WO-2025103927-A1 | SUBSTITUTED OXYIMINOMETHYLPHENYL URACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2025-05-22 | — | — | WO | disclosed |
| WO-2025103931-A1 | SUBSTITUTED CYCLOPROPYLOXYPHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2025-05-22 | — | — | WO | disclosed |
| WO-2025103929-A1 | SUBSTITUTED N-BENZOIC ACID URACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2025-05-22 | — | — | WO | disclosed |
| EP-4440314-A1 | (1,4,5-TRISUBSTITUTED-1H-PYRAZOLE-3-YL)OXY-2-ALKOXYTHIO ALKYL ACIDS AND DERIVATIVES THEREOF, THEIR SALTS AND THEIR USE AS HERBICIDAL ACTIVE AGENTS | Bayer Aktiengesellschaft (DE) | 2024-10-09 | — | — | EP | disclosed |
| WO-2024194026-A1 | 4-DIFLUOROMETHYL BENZAMIDES WITH HERBICIDAL ACTION | BAYER AKTIENGESELLSCHAFT (DE) | 2024-09-26 | — | — | WO | disclosed |
| WO-2024104952-A1 | SUBSTITUTED CYCLOPROPYLOXYPHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-05-23 | — | — | WO | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| CN-101172981-A | 2,3-dihydroimidazo[2,1-b]oxazole compound | OTSUKA PHARMA CO LTD (JP) | 2008-05-07 | — | — | CN | disclosed |
| CN-100366624-C | 2, 3-dihydro-6-nitroimidazo [2,1-b ] * azole compounds | OTSUKA PHARMA CO LTD (JP) | 2008-02-06 | — | — | CN | disclosed |
| EP-1678185-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-07-12 | — | — | EP | disclosed |
| CN-1705670-A | 2, 3-dihydro-6-nitroimidazo [2, 1-b ] oxazole compounds | OTSUKA PHARMA CO LTD (JP) | 2005-12-07 | — | — | CN | disclosed |
| WO-2005042542-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-05-12 | — | — | WO | disclosed |
| EP-0161550-B1 | PROCESS FOR PRODUCING AN ALIPHATIC ISOCYANATE | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1988-01-20 | — | — | EP | disclosed |
| US-4587056-A | CARBONYLATION, OXIDATION, CATALYST | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1986-05-06 | — | — | US | disclosed |
| EP-0161550-A1 | Process for producing an aliphatic isocyanate | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1985-11-21 | — | — | EP | disclosed |
| US-4537622-A | POSTEMERGENECE HERBICIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | ALDH1A1 412/4885POLB 757/4885TDP1 4548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.